Cardiac Science offers the Powerheart AED G3 Pro. The company's latest boasts a ECG color display, manual override features, multiple rescue capability, and advanced technology ...

With a host of benefits, the G3 Pro comes fully equipped with:+ Color ECG display, manual override, and 3–lead ECG monitoring capabilities.+ Our patented Rescue Ready technology ...

The Powerheart AED G3 Pro is designed for the professional rescuer with a color display screen, manual override, and 3-lead ECG monitoring capabilities.

The Powerheart AED G3 Plus is the flagship Cardiac Science AED (automated external defibrillator), complete with RescueCoach and CPR metronome to pace chest compressions.

Cardiac Science is offering exclusive pricing on AED packages including the Powerheart G5 AED, the Powerheart G3 Plus AED, Rescue Ready® Management Services, and AED accessories.

The Powerheart is now available in 32 countries, including the Czech Republic and Australia. Cardiac hopes to double sales for the device this year to more than $8 million, Cohen said.

Cardiac Science, a manufacturer of automated external defibrillators headquartered in Waukesha, has unveiled the Powerheart G5 AED. It is the first FDA-cleared AED to combine fully automatic shock ...

Opto Circuits’ wholly owned subsidiary Cardiac Science is now looking to expand in the Asia-Pacific region with its Powerheart G3 automated external defibrillation (AED). It holds around 100 patents ...

Opto Circuits’ group company, Cardiac Science Corporation, will supply Powerheart G3 AEDs to all Chicago-area Metra commuter trains and other Metra facilities by the end of January.

The AED, a Powerheart G3 from Cardiac Science, was used within five minutes by Allan Murphy, a fast-acting member of the Gartsherrie Engineering Ltd team, saving the contractor’s life. An ambulance ...

Along with its sister AED, the Powerheart G3, the Powerheart G5 is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered SCA, a condition ...

Investors bought more shares of Opto Circuits India on Wednesday after its subsidiary received approval from the USFDA for its Powerheart G5 AED with CRPD. The stock rallied 14 percent intraday.